Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 9, 2007, Pages 3225-3229

  Gould, Carolyn V ^a,c   Sniegowski, Paul D ^a   Shchepetov, Mikhail ^a   Metlay, Joshua P ^a,b   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM MUTANT; GYRA GENE; MINIMUM INHIBITORY CONCENTRATION; MISMATCH REPAIR; MISSENSE MUTATION; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; PARE GENE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DNA REPAIR; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; QUININE; STREPTOCOCCUS PNEUMONIAE;

EID: 35948988830     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00336-07     Document Type: Article

References (35)

1. Balganesh, T. S., and S. A. Lacks. 1985. Heteroduplex DNA mismatch repair system of Streptococcus pneumoniae: cloning and expression of the hexA gene. J. Bacteriol. 162:979-984.
2. Balsalobre, L., M. J. Ferrándiz, J. Liñares, F. Tubau, and A. G. de la Campa. 2003. Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:2072-2081.
3. Chen, D., A. McGeer, J. De Azavedo, and D. Low. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233-239.
4. del Campo, R., M.-I. Morosini, E. G.-G. de la Pedrosa, A. Fenoll, C. Muñoz-Almagro, L. Máiz, F. Baquero, R. Cantón, and the Spanish Pneumococcal Infection Study Network. 2005. Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. J. Clin. Microbiol. 43:2207-2214.
5. Gillespie, S. H., L. L. Voelker, J. E. Ambler, C. Traini, and A. Dickens. 2003. Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation. Microb. Drug Resist. 9:17-24.
6. Giraud, A., I. Matic, O. Tenaillon, A. Clara, M. Radman, M. Fons, and F. Taddei. 2001. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291:2606-2608.
7. Heffelfinger, J., S. Dowell, J. Jorgensen, K. Klugman, L. Mabry, D. Musher, J. Plouffe, A. Rakowsky, A. Schuchat, C. Whitney, and the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. 2000. Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch. Intern. Med. 160:1399-1408.
8. Ho, P.-L., T.-L. Que, D. N.-C. Tsang, T.-K. Ng, K.-H. Chow, and W.-H. Seto. 1999. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 43:1310-1313.
9. Hooper, D. 2001. Mechanism of action of antimicrobials: focus on fluoroquinolones. Clin. Infect. Dis. 32(Suppl. 1):S9-S15.
10. Janoir, C., V. Zeller, M.-D. Kitzis, N. J. Moreau, and L. Gutmann. 1996. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob. Agents Chemother. 40:2760-2764.
11. Lea, D., and C. Coulson. 1949. The distribution of the numbers of mutants in bacterial populations. J. Genet. 49:264-285.
12. LeClerc, J. E., B. Li, W. L. Payne, and T. Cebula. 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274:1208-1211.
13. Luria, S. E., and M. Delbrück. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
14. Ma, W., G. Sandri, and S. Sarkar. 1992. Analysis of the Luria-Delbrück distribution using discrete convolution powers. J. Appl. Prob. 29:255-267.
15. Mandell, L. A., J. G. Bartlett, S. F. Dowell, T. M. File, Jr., D. M. Musher, and C. Whitney. 2003. Update on practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. 37:1405-1433.
16. Mao, E. F., L. Lane, J. Lee, and J. H. Miller. 1997. Proliferation of mutators in a cell population. J. Bacteriol. 179:417-422.
17. Mejean, V., C. Salles, L. C. Bullions, M. J. Bessman, and J. P. Claverys. 1994. Characterization of the mutX gene of Streptococcus pneumoniae as a homologue of Escherichia coli mutT, and tentative definition of a catalytic domain of the dGTP pyrophosphohydrolases. Mol. Microbiol. 11:323-330.
18. Morosini, M.-I., M.-R. Baquero, J. M. Sánchez-Romero, M.-C. Negri, J.-C. Galán, R. del Campo, J. C. Pérez-Diaz, and F. Baquero. 2003. Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob. Agents Chemother. 47:1464-1467.
19. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing: 12th informational supplement. National Committee for Clinical Laboratory Standards, Wayne, PA.
20. Negri, M. C., M. I. Morosini, M. R. Baquero, R. del Campo, J. Blázquez, and F. Baquero. 2002. Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations. Antimicrob. Agents Chemother. 46:528-530.
21. Oliver, A., R. Cantón, P. Campo, F. Baquero, and J. Blázquez. 2000. High frequency of hypermutable Pseudomonas aeruginosa isolates in cystic fibrosis lung infection. Science 288:1251-1254.
22. Örlén, H., and D. Hughes. 2006. Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 50:3454-3456.
23. Pan, X.-S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
24. Pericone, C. D., D. Bae, M. Shchepetov, T. McCool, and J. N. Weiser. 2002. Short-sequence tandem and nontandem DNA repeats and endogenous hydrogen peroxide production contribute to genetic instability of Streptococcus pneumoniae. J. Bacteriol. 184:4392-4399.
25. Prunier, A. L., B. Malbruny, M. Laurans, J. Brouard, J. F. Duhamel, and R. Leclerc. 2003. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J. Infect. Dis. 187:1709-1716.
26. Richter, S. S., K. P. Heilmann, S. E. Beekmann, N. J. Miller, C. L. Rice, and G. V. Doern. 2005. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations. Clin. Infect. Dis. 40:225-235.
27. Román, F., R. Cantón, M. Pérez-Vázquez, F. Baquero, and J. Campos. 2004. Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J. Clin. Microbiol. 42:1450-1459.
28. Rosche, W. A., and P. L. Foster. 2000. Determining mutation rates in bacterial populations. Methods 20:4-17.
29. Samrakandi, M. M., and F. Pasta. 2000. Hyperrecombination in Streptococcus pneumoniae depends on an atypical mutY homologue. J. Bacteriol. 182:3353-3360.
30. Sanders, C. 2001. Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clin. Infect. Dis. 32(Suppl. 1):S1-S8.
31. Shaver, A. C., and P. D. Sniegowski. 2003. Spontaneously arising mutL mutators in evolving Escherichia coli populations are the result of changes in repeat length. J. Bacteriol. 185:6076-6082.
32. Sniegowski, P. D., P. J. Gerrish, T. Johnson, and A. C. Shaver. 2000. Evolution of mutation rates: separating causes from consequences. Bioessays 22:1057-1066.
33. Sniegowski, P. D., P. J. Gerrish, and R. E. Lenski. 1997. Evolution of high mutation rates in experimental populations of Escherichia coli. Nature 387:703-705.
34. Stewart, F. 1994. Fluctuation tests: how reliable are the estimates of mutation rates? Genetics 137:1139-1146.
35. Tiraby, J. G., and M. S. Fox. 1973. Marker discrimination in transformation and mutation of pneumococcus. Proc. Natl. Acad. Sci. USA 70:3541-3545.